Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL813642 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL832778 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL28959399 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL725625 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL2578973 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL11544701 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL10338273 | 1.00 | FFAR3 (0.50) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL27896643 | 0.91 | FFAR3 (0.41) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL28919486 | 0.88 | FFAR3 (0.39) | FFAR3LCKFYNALDH1A1TSHR | |
| Propionic Acid SCHEMBL11588668 | 0.88 | FFAR3 (0.56) | FFAR3LCKFYNALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 863 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118420-A | Ultraviolet-resistant fluoropolymer film and application thereof | 浙江省化工研究院有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120083913-A | Drag reducing composition, preparation method thereof and pipeline drag reducer | 广昌达新材料技术服务（深圳）股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-116426058-B | Polyethylene casting film and preparation method thereof | 天津市中泰创展科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-114203337-B | High-resilience solar cell front silver paste and preparation method thereof | 江苏聚盈新材料科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118139925-A | Polyvinyl acetal resin composition, inorganic fine particle dispersion slurry composition, and laminated ceramic capacitor | 积水化学工业株式会社 | 2024-06-04 | — | — | CN | claimed |
| CN-118086986-A | High-coverage electroplated copper additive composition for printed circuit board | 广东利尔化学有限公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2023189847-A1 | POLYVINYL ACETAL RESIN COMPOSITION, INORGANIC-PARTICLE-DISPERSED SLURRY COMPOSITION, AND MULTILAYER CERAMIC CAPACITOR | 積水化学工業株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-116426058-A | Polyethylene casting film and preparation method thereof | 天津市中泰创展科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-112516085-B | Tilmicosin solution and preparation method and use method thereof | 佛山市正典生物技术有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115844790-A | Hair conditioner and preparation method thereof | 北京普世安生物科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| WO-2012082517-A2 | CONTROLLED DEGRADATION FIBERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-06-21 | — | — | WO | claimed |
| US-20090297496-A1 | Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases | CHILDRENS HOSPITAL MEDICAL CENTER (US) | 2009-12-03 | — | — | US | claimed |
| US-7517924-B1 | Starch ester blends with linear polyesters | JAPAN CORN STARCH CO., LTD. (JP) | 2009-04-14 | — | — | US | claimed |
| US-20070249692-A1 | INHIBITORS OF CRYSTALLIZATION IN A SOLID DISPERSION | ABBVIE INC. | 2007-10-25 | — | — | US | claimed |
| WO-2007030375-A2 | LYSOSOMAL ACID LIPASE THERAPY FOR NAFLD AND RELATED DISEASES | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2007-03-15 | — | — | WO | claimed |
| WO-2005023305-A2 | MODULATING CELL ACTIVITY BY USING AN AGENT THAT REDUCES THE LEVEL OF CHOLESTEROL WITHIN A CELL | INPHARMATICA LIMITED (GB) | 2005-03-17 | — | — | WO | claimed |
| US-6306203-B1 | FOR USE IN INK JET PRINTING, INCLUDING PIEZOELECTRIC INK JET PRINTING AND ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-10-23 | — | — | US | claimed |
| WO-2001000684-A1 | LIQUID OLIGOMERS CONTAINING UNSATURATION | ASHLAND INC. (US) | 2001-01-04 | — | — | WO | claimed |
| US-5403426-A | Surface treatment | HERCULES INCORPORATED (US) | 1995-04-04 | — | — | US | claimed |
| CN-1073457-A | Produce the method for plasticised polyvinyl alcohol and be used to prepare the thermoplastic compounds of starch-based, biodegradable | NOVAMONT SPA (IT) | 1993-06-23 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090297496-A1 | Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases | LIPC, PNLIP, LIPA | FFAR3 137/4885LCK 4255/4885FYN 3369/4885 |
| US-20070249692-A1 | INHIBITORS OF CRYSTALLIZATION IN A SOLID DISPERSION | GYS2, CSPP1, RCC1 | FFAR3 3880/4885LCK 3597/4885FYN 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.